Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity

By Ehrlich H.J.   Pavlova B.G.   Fritsch S.   Poellabauer E.-M.   Loew-Baselli A.   Obermann-Slupetzky O.   Maritsch F.   Cil I.   Dorner F.   Barrett P.N.  

Vaccine, Vol. 22, Iss. 2, 2003-12 ,pp. : 217-223

Elsevier

Access to resources Recommend Favorite

Tolerability of modified tick-borne encephalitis vaccine FSME-IMMUN ''NEW'' in children: results of post-marketing surveillance

By Pavlova B.G.   Loew-Baselli A.   Fritsch S.   Poellabauer E.-M.   Vartian N.   Rinke I.   Ehrlich H.J.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 742-745

Elsevier

Access to resources Recommend Favorite

Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults

By Zent O.   Beran J.   Jilg W.   Mach T.   Banzhoff A.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 738-741

Elsevier

Access to resources Recommend Favorite

Vaccination against tick-borne encephalitis (TBE): influence of simultaneous application of TBE immunoglobulin on seroconversion and rate of adverse events

By Hedenstrom M.v.   Heberle U.   Theobald K.  

Vaccine, Vol. 13, Iss. 8, 1995-06 ,pp. : 759-762

Elsevier

Access to resources Recommend Favorite

Antigen dependent adverse reactions and seroconversion of a tick-borne encephalitis vaccine in children

By Eder G.   Kollaritsch H.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3575-3583

Elsevier

Access to resources Recommend Favorite